Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System, Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Soldo D, Grizelj B, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I, Pharmaceuticals (Basel), Pharmaceuticals, 2025 Jun 19;18(6):928
Emerging data suggests that co-activation of both CTR and AMYRs may confer greater efficacy in metabolic control than selective activation of AMYRs 13
Manual dose entry still works
This synthetic peptide fragment derived from human growth hormone (amino acids 176-191) has been specifically engineered to isolate the fat-metabolizing properties of growth hormone while completely eliminating effects on insulin-like growth factor 1 (IGF-1), blood glucose regulation, and tissue growth
It has benefits in many situations